Gene ID 3067
Formulation 50 µg (0.2 mg/ml) in phosphate buffered saline (PBS), pH 7.2, containing 0.1% BSA and 0.02% thimerosal.
Antibody Target HDC
Shipping gel pack
Concentration 0.2 mg/ml
Storage Temp. -20 °C
Appearance Colorless liquid
Research Use For Rersearch Use Only! Not to be used in humans.
Shelf Life 1 year
Handling The peptide solution should be gently mixed before use.
Test You can block the antibody by the specific target amino acid sequence of peptide.
Properties blocking peptide
Description Peptides short amino acid chains or epitopes or blocking antagonists. The shortest peptides are dipeptides, consisting of 2 amino acids joined by a single peptide bond, followed by tripeptides, tetra peptides, ... till polypeptides that are long, continuous, and unbranched synthetic peptide chains. These biological oligomers and polymers can be Solid-phase peptide synthesis (SPPS), or in continue produced for custom peptide synthesis projects. The High-efficiency solid phase peptide synthesis (HE-SPPS) is give very low production costs.
Short name HDC Blocking Peptide
Technique blocking peptide, Blocking, peptide
Alternative name histidine decarboxylase inhibiting short protein sequence
Alternative technique control
Alternative to gene target histidine decarboxylase, HDC and IDBG-11604 and ENSG00000140287 and 3067, pyridoxal phosphate binding, Cytoplasm, Hdc and IDBG-204118 and ENSMUSG00000027360 and 15186, HDC and IDBG-646667 and ENSBTAG00000009911 and 515950